Guardion Health stock tumbles after reverse stock split announcement

Dow Jones2021-02-26

MW Guardion Health stock tumbles after reverse stock split announcement

Shares of Guardion Health Sciences Inc. (GHSI) tumbled 24.0% in premarket trading Friday, after the medical foods company focused on ocular health said it was implementing a 1-for-6 reverse stock split, to help maintain listing requirements. The reverse split will go into effect with the opening of trading on March 1, meaning stock price on Monday will start at six-times Friday's closing price. The company said on Sept. 20, it received a letter from the Nasdaq's listing qualifications department regarding noncompliance with the $1.00 per share minimum bid price requirement. The stock had closed at 20 cents on Sept. 30, then rose to a closing high of $1.16 on Feb. 16, before tumbling to close Thursday at 69 cents. In the company's latest quarterly filing in November and annual report filed a year ago, the company has said there is substantial doubt about its ability to continue as a going concern. Reverse stock splits are often viewed by investors as confirmation of a companies troubles over the past 12 months, while the S&P 500 has gained 22.9%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

 

$(END)$ Dow Jones Newswires

February 26, 2021 08:57 ET (13:57 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1